Johnson & Johnson Ordered To Pay $572.1M For Oklahoma Opioid Abatement Program

(August 27, 2019, 10:46 AM EDT) -- NORMAN, Okla. — An Oklahoma state court judge on Aug. 26 ordered Johnson & Johnson and subsidiary Janssen Pharmaceuticals Inc. to pay $572.1 million to fund the first year of the state’s opioid crisis abatement plan (Oklahoma, ex rel., Mike Hunter, et al. v. Purdue Pharma L.P., et al., No. CJ-2017-816, Okla. Dist., Cleveland Co.). VIDEO OF JUDGMENT SUMMARY AVAILABLE....